Joseph Truitt

Mr. Truitt was appointed Achillion’s Chief Executive Officer in May 2018. Mr. Truitt joined Achillion in January 2009 from Viropharma, Inc. following its acquisition of Lev Pharmaceuticals. At Lev, Mr. Truitt was most recently Vice President of Business Development and Product Strategy and led the build out of the commercial team and infrastructure in preparation for product launch. Mr. Truitt joined Lev from Johnson & Johnson, where he was Vice President of Sales and Operations and directed commercial operations and had P&L responsibility for sales, operations and national accounts at the company’s OraPharma subsidiary. Mr. Truitt holds a BS degree in Marketing from LaSalle University, Philadelphia, and an MBA degree from St. Joseph’s University, Philadelphia.

Joseph Truitt is the Chief Executive Officer & Boar Member at iECURE, based in United States, North America. With a background in Biotechnology, Joseph Truitt has a rich history of leadership and innovation.Joseph Truitt studied BS Marketing at La Salle University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.